Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study (Q45855897)
Jump to navigation
Jump to search
scientific article published on September 10, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study |
scientific article published on September 10, 2010 |
Statements
1 reference
Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study (English)
1 reference
Katalin Boér
1 reference
István Láng
1 reference
Antonio Llombart-Cussac
1 reference
Inger Andreasson
1 reference
Nick Sanders
1 reference
Elizabeth Murray
1 reference
Guillermo L. Vivanco
10 September 2010
1 reference
1 reference
1 reference
30
1 reference
2
1 reference
681-687
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference